BC Innovations | May 26, 2011
Distillery Therapeutics

Indication: Cancer

This week in therapeutics Cancer Melanoma Protein kinase D3 (PRKD3); BRAF; CRAF (RAF1) In vitro studies suggest inhibiting PRKD3 could help increase the sensitivity of melanomas to BRAF and CRAF inhibitors. In melanoma cells resistant...
BC Innovations | May 26, 2011
Distillery Therapeutics

Indication: Autoimmune disease

This week in therapeutics Autoimmune disease Autoimmune disease CD28; inducible T cell co-stimulator ligand (ICOSLG; B7-H2) In vitro and cell culture studies suggest inhibiting interactions between B7-H2 and CD28 could help treat autoimmune disease. An...
Items per page:
1 - 2 of 2